Phathom Pharmaceuticals, Inc. (PHAT) Insider Trading

Phathom Pharmaceuticals, Inc. (PHAT) has 2 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 8, 2026.

Filings
2
Purchases
0
$0
Sales
0
$0
Insiders
1

Most active PHAT insiders

Breedlove Robert Charles
Principal Accounting Officer
0 bought · 0 sold · Sept. 8, 2026
$21K

Latest PHAT Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Sept. 8, 2026 filed Sept. 3, 2026 Breedlove Robert Charles Principal Accounting Officer $4,163 460 −1% No
July 16, 2026 filed July 14, 2026 Breedlove Robert Charles Principal Accounting Officer $17,159 1,555 −3% No

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when PHAT insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free